🇫🇷 France Country × Condition
multiple myeloma Clinical Trials in France
Active clinical trials for multiple myeloma with research sites in France. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 6 // Recruiting: 6 Phases: Phase 2, Phase 3 // Updated: Daily
Total Trials
6
Recruiting Now
6
Country
🇫🇷 France
Active Trials in France (6)
NCT05945524
Recruiting
Analysis of the Resistance and Sensitivity Mechanisms to Teclistamab by Focusing on Single Immune Cell Examination
Enrollment
100 pts
Country
🇫🇷 France
University Hospital, Toulouse
View Trial → NCT05572229 Phase 2
Recruiting
Study of Teclistamab in Combination in Elderly Patients With Multiple Myeloma
Enrollment
74 pts
Country
🇫🇷 France
University Hospital, Lille
View Trial → NCT03807128
Recruiting
MYeloma Resistance And Clonal Evolution
Enrollment
1,400 pts
Country
🇫🇷 France
Nantes University Hospital
View Trial → NCT05203003
Recruiting
Prospective Evaluation of the Prognostic Impact of Measurable Residual Disease (MRD) Within a Phase III Study Comparing a Fixed Duration Therapy Versus Continuous Therapy With Daratumumab, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma Requiring a First Salvage Treatment.
Enrollment
260 pts
Country
🇫🇷 France
Assistance Publique - Hôpitaux de P...
View Trial → NCT06561854 Phase 3
Recruiting
Study Comparing Therapy for Advanced Relapsed/Refractory Multiple Myeloma With and Without Dexamethasone
Enrollment
318 pts
Country
🇫🇷 France
Assistance Publique - Hôpitaux de P...
View Trial → NCT06409767
Recruiting
Impact of an Early Warning System on the Prognosis of Patients With Hematological Malignancies Receiving Intensive Chemotherapy With or Without Hematopoietic Cell Transplantation.
Enrollment
2,224 pts
Country
🇫🇷 France
University Hospital, Angers
View Trial → Frequently Asked Questions
How many multiple myeloma clinical trials are active in France?
There are currently 6 active clinical trials for multiple myeloma with sites in France, of which 6 are actively recruiting patients.
How can I join a multiple myeloma clinical trial in France?
To join a multiple myeloma clinical trial in France, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in France directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are multiple myeloma trials in France?
Active multiple myeloma trials in France span Phase 2, Phase 3. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology